FEATURED/ARCHIVES (08/05/24)
A Smartphone App to Promote Patient Activation and Support Shared Decision-Making in People with a Diagnosis of Schizophrenia in Outpatient Treatment Settings (Momentum Trial): Randomized Controlled Assessor-Blinded Trial · October 2022
Articles
Journal of Medical Internet Research
Managing Pain and Psychosis Symptoms in Nursing Home Patients: Results from a Cluster-Randomized Controlled Trial (COSMOS) · June 2021
Articles
Journal of the American Medical Directors Association
Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-Up Survey After the Randomized Controlled Trial Discontinuation · April 2022
Articles
JMIR mHealth and uHealth
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
Reducing Antipsychotic Drugs in Stable Patients with Chronic Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Pilot Trial · February 2020
Articles
European Archives of Psychiatry and Clinical Neuroscience
Cost and Quality-of-Life Impacts of Community Treatment Orders (CTOs) for Patients with Psychosis: Economic Evaluation of the OCTET Trial · July 2020
Articles
Social Psychiatry and Psychiatric Epidemiology
Integrated Cognitive-Behavioral Social Skills Training and Compensatory Cognitive Training for Negative Symptoms of Psychosis: Effects in a Pilot Randomized Controlled Trial · October 2021
Articles
Schizophrenia Bulletin
Cerebellar Theta Burst Stimulation for the Treatment of Negative Symptoms of Schizophrenia: A Multicenter, Double-Blind, Randomized Controlled Trial · September 2021
Articles
Psychiatry Research
Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results from a Multisite Randomized Trial · September 2021
Articles
Psychiatric Services
Antipsychotics for Negative and Positive Symptoms of Schizophrenia: Dose-Response Meta-Analysis of Randomized Controlled Acute Phase Trials · September 2021
Articles
NPJ Schizophrenia
Lurasidone in Adolescents and Adults with Schizophrenia: From Clinical Trials to Real-World Clinical Practice · November 2022
Articles
Expert Opinion on Pharmacotherapy
The Promotion of Mental Health and Prevention of First-Episode Psychosis: A Pilot and Feasibility Non-Randomised Clinical Trial · November 2023
Articles
International Journal of Environmental Research and Public Health
Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) in Patients with Remitted Psychosis: A 2-Year Randomized Controlled Trial with a Naturalistic Cohort · March 2023
Articles
Psychological Medicine
Abnormally Low Prolactin Levels in Schizophrenia Patients After Switching to Aripiprazole in a Randomized Trial: A Biomarker for Rebound in Psychotic Symptoms? · November 2020
Articles
BMC Psychiatry
The Effect of Attentional Avoidance, Attentional Focusing, and Mindfulness on the Frequency of Voice-Hearing and Associated Distress in People with Schizophrenia: A Randomized Controlled trial · April 2023
Articles
Iranian Journal of Psychiatry
Effectiveness of a Therapeutic Educational Oral Health Program for Persons with Schizophrenia: A Cluster Randomized Controlled Trial and Qualitative Approach · July 2023
Articles
Healthcare
Cognitive Change and Antipsychotic Medications: Results from a Pragmatic Rater-Blind RCT · June 2021
Articles
Schizophrenia Research: Cognition
A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis · July 2021
Articles
International Journal of Environmental Research and Public Health
Efficacy of Metacognitive Training for Patients with Schizophrenia in Psychiatric Emergency Wards: A Pilot Randomized Controlled Trial · April 2022
Articles
Frontiers in Psychology
The Effect of Memantine versus Folic Acid on Cognitive Impairment in Patients with Schizophrenia: A Randomized Clinical Trial · June 2023
Articles
Iranian Journal of Psychiatry